Activation of EphA1-Epha receptor axis attenuates diabetic nephropathy in mice
Authors:
- 1 May 2017
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 486 (3) , 693-699
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- EphA4 Receptor Forward Signaling Inhibits Glucagon Secretion From α-CellsDiabetes, 2015
- Ephrin–Eph signaling as a potential therapeutic target for the treatment of myocardial infarctionMedical Hypotheses, 2013
- Silence of TRIB3 Suppresses Atherosclerosis and Stabilizes Plaques in Diabetic ApoE−/−/LDL Receptor−/− MiceDiabetes, 2012
- Eph-Ephrin Bidirectional Signaling in Physiology and DiseaseCell, 2008
- Upregulation of EphA2 during in vivo and in vitro renal ischemia-reperfusion injury: role of Src kinasesAmerican Journal of Physiology-Renal Physiology, 2006
- Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosisNephrology Dialysis Transplantation, 2004
- Nephropathy in Patients with Type 2 DiabetesNew England Journal of Medicine, 2002
- Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and NephropathyNew England Journal of Medicine, 2001
- The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic NephropathyNew England Journal of Medicine, 1993
- A novel immediate-early response gene of endothelium is induced by cytokines and encodes a secreted protein.Molecular and Cellular Biology, 1990